1. INHIBITOR Therapeutics, Inc.

    0 Comments Leave a Comment

    1-1 of 1
    1. Mentioned In 1 Articles

    2. INHIBITOR Therapeutics Appoints Dr. Debra Peattie to its Board of Directors

      INHIBITOR Therapeutics Appoints Dr. Debra Peattie to its Board of Directors
      TAMPA, Fla., Oct. 31, 2019 /PRNewswire/ -- INHIBITOR Therapeutics, Inc. (OTCQB: INTI), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics to inhibit the progression of cancerous and non-cancerous proliferation disorders, today announced that Debra Peattie, PhD, MBA has been appointed as an independent member of its Board of Directors...
      Read Full Article
    3. 1-1 of 1
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content